Pesquisar
Nanobiotix SA
NBTXAdicionar à lista de desejos
39.480USD
+1.780+4.72%
Fechamento 07/01, 16:00（ET）Cotações atrasadas em 15 min
1.92BValor de mercado
PerdaP/L TTM
Mais detalhes de Nanobiotix SA Empresa
Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.
Informações de Nanobiotix SA
Código da empresaNBTX
Nome da EmpresaNanobiotix SA
Data de listagemOct 29, 2012
CEOLevy (Laurent)
Número de funcionários108
Tipo de títulosDepository Receipt
Fim do ano fiscalOct 29
Endereço60 rue de Wattignies
CidadePARIS
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísFrance
Código postal75012
Telefone33140260470
Sitehttps://www.nanobiotix.com
Código da empresaNBTX
Data de listagemOct 29, 2012
CEOLevy (Laurent)
Executivos da empresa Nanobiotix SA
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Laurent Levy, Ph.D.
Dr. Laurent Levy, Ph.D.
Chief Executive Officer
Chief Executive Officer
--
--
Dr. Alain Herrera
Dr. Alain Herrera
Independent Director
Independent Director
--
--
Ms. Anne-Marie Graffin
Ms. Anne-Marie Graffin
Independent Vice Chairwoman of the of the Board
Independent Vice Chairwoman of the of the Board
--
--
Mr. Enno Spillner
Mr. Enno Spillner
Independent Director
Independent Director
--
--
Dr. Gary M. Phillips, M.D.
Dr. Gary M. Phillips, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Bart Van Rhijn
Mr. Bart Van Rhijn
Chief Financial & Business Officer
Chief Financial & Business Officer
--
--
Ms. Anne-Juliette Hermant
Ms. Anne-Juliette Hermant
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Dr. Louis Kayitalire, M.D.
Dr. Louis Kayitalire, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Craig West
Mr. Craig West
Senior Vice President - Investor Relations
Senior Vice President - Investor Relations
--
--
Ms. Anne-Sophie Lariviere
Ms. Anne-Sophie Lariviere
Vice President - Strategy & Operational Excellence
Vice President - Strategy & Operational Excellence
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Laurent Levy, Ph.D.
Dr. Laurent Levy, Ph.D.
Chief Executive Officer
Chief Executive Officer
--
--
Dr. Alain Herrera
Dr. Alain Herrera
Independent Director
Independent Director
--
--
Ms. Anne-Marie Graffin
Ms. Anne-Marie Graffin
Independent Vice Chairwoman of the of the Board
Independent Vice Chairwoman of the of the Board
--
--
Mr. Enno Spillner
Mr. Enno Spillner
Independent Director
Independent Director
--
--
Dr. Gary M. Phillips, M.D.
Dr. Gary M. Phillips, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Bart Van Rhijn
Mr. Bart Van Rhijn
Chief Financial & Business Officer
Chief Financial & Business Officer
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de Nanobiotix SA?
Os cinco principais acionistas de Nanobiotix SA são: Dr. Laurent Levy, Ph.D.
Quantas instituições possuem ações da Nanobiotix SA (NBTX)?
Em 2026Q1, 30 instituições possuíam ações da Nanobiotix SA, com valor de mercado aproximado de 5.71M, representando 11.79% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -3044728.00.